Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Oct 04, 2024 4:15pm
20 Views
Post# 36253860

RE:RE:New VP Business Development - Europe

RE:RE:New VP Business Development - EuropeI always considered you a enthusiastic supporter, big difference between that and a pumper. Pumpers have a cult like air about them.

Pumpers could be that kind of person who posts bid/asks on an OTC exchange and then gloats or hurts insults and invective at anyone who challenges them. Such tiny and insecure minds.

LithLover wrote: Even though people on here were calling me a pumper I always knocked the company for their lack of marketing and sales.  Basic SEO, website, pop up clinics, ideas to give away free tests, 2 for 1 for testing for families, relationships with private health clinics, x number free tests to fire fighters (first 50 free). 

The lack of a VP or Director Sales was always concerning when trying to sign partners, employer groups and generate tests.  Yes its a dianostic liquid biopsy company but its also a sales company.

I dont know if this VP Biz Dev Europe will drive much business but its a positive sign that they made the hire and recognize the need for a senior level sales position.  Now they need a VP sales and a sales team in North America to coincide with the new Aristotle "relaunch" Tripp just mentioned in the last press release.  Operational costs have been cut, now its time to drive sales of Aristotle not COC not AVRT.  The only way this company survives is Aristotle and a focus on sales and revenues.  Period.  


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse